Status: Recruiting
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called human allogeneic mesenchymal stem cell therapy.
Participants needed: 136
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Joshua M HareUpdated: Mar 24, 2026Locations: 4
Eligibility criteria
Men and women aged 18 to 80 years (inclusive) at the time of signing the informe... [+4]
Be eligible for or require standard-of-care surgical or percutaneous interventio... [+36]